Long-term Skeletal Muscle Protection After Gene Transfer in a Mouse Model of LGMD-2D
Open Access
- 1 October 2007
- journal article
- Published by Elsevier in Molecular Therapy
- Vol. 15 (10) , 1775-1781
- https://doi.org/10.1038/sj.mt.6300246
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Limb-Girdle Muscular Dystrophy in the United StatesJournal of Neuropathology and Experimental Neurology, 2006
- Noninvasive monitoring of gene correction in dystrophic muscleMagnetic Resonance in Medicine, 2005
- Noninvasive monitoring of muscle damage during reloading following limb disuseMuscle & Nerve, 2005
- Delivery ofα- andβ-Sarcoglycan by Recombinant Adeno-Associated Virus: Efficient Rescue of Muscle, but Differential ToxicityHuman Gene Therapy, 2002
- Early adenovirus-mediated gene transfer effectively prevents muscular dystrophy in alpha-sarcoglycan-deficient miceGene Therapy, 2000
- Clinical Protocol: Phase I Clinical Trial Utilizing Gene Therapy for Limb Girdle Muscular Dystrophy: alpha-, beta-, gamma-, or delta-Sarcoglycan Gene Delivered with Intramuscular Instillations of Adeno-Associated VectorsHuman Gene Therapy, 2000
- Recombinant Adeno-Associated Viral Vectors Mediate Long-Term Transgene Expression in MuscleHuman Gene Therapy, 1997
- Gene delivery to skeletal muscle results in sustained expression and systemic delivery of a therapeutic proteinProceedings of the National Academy of Sciences, 1996
- Isolation and characterization of human muscle cells.Proceedings of the National Academy of Sciences, 1981
- Physical map and strand polarity of specific fragments of adenovirus-associated virus DNA produced by endonuclease R-EcoRIJournal of Virology, 1975